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Science and Society: Some
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for Improving Integration
Patricia Kosseim and Sheila Chapman
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In this article, the authors describe relatively recent efforts by scientiﬁc research agen-
cies to promote, through various funding programs, the integration of social sciences
and humanities with the natural sciences. This “integrated” approach seeks to study
science through a broader interdisciplinary lens in order to better anticipate, under-
stand, and address its ethical, legal, and social implications. The authors review the
origins and evolution of this trend, as well the arguments which have been formulated
by both proponents and critics of integration. By using Genome Canada’s “GE3LS”
Research Program as a case study, the authors discuss the successes and continuing
challenges of this model based on evaluation results available to date. The authors
then go on to examine and compare three possible models for improving the future suc-
cess of the GE3LS research program, including: 1) enhancing the current integrated
research approach through incremental reﬁnements based on concrete evidence and
lessons learned; 2) promoting greater interaction and synergy across GE3LS research
projects through a deliberate, systematic and coordinated “hub and spoke” approach;
and 3) taking a broad programmatic approach to GE3LS research by creating a central
resource of available expertise and advisory capacity.
Keywords: ELSI, GE3LS, genomics, integration, science, society
INTRODUCTION
Ever since James Watson, the ﬁrst Director of the U.S. National Human
Genome Research Institute (NHGRI), publicly announced at a press confer-
ence in 1988 that the National Institutes of Health (NIH) should direct funds
to the study of the ethical, legal, and social implications (ELSI)o ft h eH u m a n
Genome Project, a new generation of related research programs eventually
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emerged at the NHGRI and elsewhere in the world (Greely, 2006; NHGRI;
Watson, 1996).
Since 2002, the U.K. Economic and Social Research Council has funded a
number of centres and institutions across the United Kingdom, all dedicated
to examining and addressing the economic and social implications of genomics
science and technologies (ESRC Genomics Network). In the Netherlands,
the Centre for Society and Genomics was created in 2004 to study, assess,
and improve the ethical, legal, and social aspects of genomics and its rela-
tionship with society (ELSA) (Centre for Society and Genomics). In 2008,
the Research Council of Norway consolidated a research program examin-
ing the ELSA aspects of biotechnology, nanotechnology and cognitive science
(Research Council of Norway). Austria, Finland, and Germany launched a
multinational initiative in 2009 calling for collaborative research projects on
ethical, legal, sociocultural, and economic aspects of genomics and related sci-
ences (ELSA-GEN, 2009). Genome Canada, created in 2000, has as one of
its objectives to examine and address the ethical, environmental, economic,
legal, and social implications of genomics (GE3LS) (Genome Canada), and the
Canadian Institutes of Health Research Institute of Genetics has, since its
inauguration in 2001, consistently held as one of its strategic research priori-
ties, the study of genetics and its ethical, legal, and social issues (GELS)( C I H R
Institute of Genetics).
Whether the recent emergence of such ELSI, ELSA, GE3LS, and other
equivalent programs is merely a modern improvisation of how research gets
funded in emerging ﬁelds such as genomics, or whether they reﬂect a more
fundamental “re-thinking” of how science relates to society more broadly is
part of a larger question which is currently being debated (Zwart and Nelis,
2009).
This article is an attempt to contribute further to that debate. Certain
limitations, however, must be acknowledged from the outset. First, this arti-
cle is largely focussed on the Canadian experience, using Genome Canada as
a case study, and may, therefore, be limited in its generalizability to other
countries. Second, there is an ongoing struggle in Canada, as elsewhere, to
determine appropriate measures for evaluating the success of different fund-
ing models for addressing the ethical, legal, and social aspects of science, and
in many respects, the jury is still out on this question. Third, the authors
have selected three Canadian-led innovations as useful models for comparing
and contrasting distinct features of integration for discussion purposes only,
though we concede that there may be several other valid models not covered
here. Finally, given the authors’ experience and background, we take a norma-
tive and programmatic approach to exploring the question of how the broader
societal implications can best be integrated into genomics research, and leave
for others better suited the philosophical and epistemological examination of
that question.196 P . Kosseim and S. Chapman
BROADER SOCIETAL CONTEXT
As a backdrop to the ongoing debate about ELSA, ELSI, GE3LS, or other equiv-
alent programs, is a larger phenomenon which seeks to “re-contextualize” the
role of science within the broader context of the society we live in.1 This emerg-
ing “Science in Society” paradigm is continually evolving as major societal
trends unfold.2
A stronger culture of public accountability and higher expectation of return
on investment now permeate both research institutions and the agencies that
fund them. Increasingly, access to scarce funding and justiﬁcation for its allo-
cation depend on the social relevance of the research and its demonstrable
beneﬁts to society.
The ubiquitous nature of information technologies, the web 2.0, and the
decentralization of “truth” have transformed institutional, disciplinary, and
professional structures of science. The democratization of knowledge and the
devolution of decision-making processes generally have broken down the tra-
ditional walls around the scientiﬁc elite and the claims of exclusivity that once
belonged to them.
Increased research collaborations between academic institutions, govern-
ments, private sector, and charitable organizations have expanded the number
of stakeholders and different perspectives that come to bear on the research.
Increased are the voices chiming into the discussion of “social relevance” and
actively engaged in shaping strategic research directions and priorities.
All of these societal trends and changing expectations have resulted in
what Gibbons coined over a decade ago as “science’s new social contract with
society” (Gibbons, 1999). More than merely a “public relations exercise,” the
process of contextualizing science in society moves scientists outside their
traditional institutions and into what Gibbons calls the “agora”—the pub-
lic space in which “science meets the public and the public speaks back to
science”—where research questions are reformulated and solutions are negoti-
ated. Contextualization urges scientists to think beyond potential applications
of their work and “internalize” its broader societal implications in order to earn
and maintain its social legitimacy (Gibbons, 1999).
Nowotny et al. describe this shift in thinking about science from one previ-
ously preoccupied with scientiﬁcally “reliable” knowledge, to one which seeks
to ensure that new knowledge is also “socially robust” (Nowotny et al., 2002,
2006; Gibbons et al., 1994). Whereas scientiﬁc “reliability” is a judgement
that resides with scientiﬁc peers having the requisite specialized expertise,
“social robustness” is an enhanced form of reliability within a broader societal
context which must be judged by a more expansive community of disciplines
and stakeholders with highly distributed knowledge, perspectives, and inter-
ests. Nowotny contends “that the more highly contextualized the knowledge
the more reliable it is likely to be—not necessarily within the reductionistScience and Society 197
framework of disciplinary science which deﬁnes reliability almost exclusively
in terms of replicability, but because it maintains valid (sic) outside these ‘ster-
ile spaces’ created by experimental and theoretical science, a condition we have
described as ‘socially robust”’ (Nowotny, 2000).
Accordingly, scientists have had to respond to these emerging trends and
changing expectations, by becoming more reﬂexive about their own roles and
impacts on society (European Communities, 2009). Social science and human-
ities (SSH) research projects, which have traditionally been funded through
separate streams and viewed as necessarily external and distant critics of sci-
ence, are becoming increasingly integrated into large-scale science projects
and/or programs. While these are ﬁelds of scholarly research in their own
right, they tend, in their integrated form, to be more speciﬁc in their exami-
nation of new technologies, their practical applications, and their implications
for society.
ARGUMENTS FOR AND AGAINST INTEGRATION
Many of these integrated science and society research programs are relatively
novel and still in the process of exploration, assessment, and reﬁnement. While
some view these programs as laudable attempts to anticipate the broader soci-
etal aspects of science, better understand their implications from multiple
perspectives, and take responsibility for addressing them, others have been
sceptical of their track record to date (Yesley, 2008; Huijer, 2006).
Notwithstanding the ostensible efforts made at the funding and program-
matic level to integrate science and society in research and the challenges
associated with implementing these, there is still a perception that the work
of SSH researchers is relegated to a secondary role in relation to the pri-
mary aims and objectives of science. Critics contend that SSH researchers
risk becoming too close to the large-scale science and vulnerable to becoming
mere promotional instruments or handmaidens of science, lacking the criti-
cal independence, academic freedom, and intellectual autonomy to contribute
meaningfully or credibly to the advancement of scholarly knowledge in their
respective disciplines (Macilwain, 2009; Zwart and Nelis, 2009). Others take
a more cynical view, seeing science-society integration as but a rhetorical con-
struct to deﬂect challenge and gain political support of government funders
and the general populace, with little serious inﬂuence or impact in practice
(Yesley, 2008; Kitcher, 2001, cited in Penders et al., 2008).
On the other hand, those who hold a more optimistic view of science
and society models recognize the many virtues of integration worth pursuing
and improving upon. Zwart and Nelis have described the integrated “ELSA”
genomics approach as having four important features (Zwart and Nelis, 2009):
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and of the concrete issues at stake, which in turn enhances the relevance,
speciﬁcity, and timeliness of their work; 2) Early anticipation moves upstream
the critical reﬂection needed to identify both desirable and undesirable impacts
on society, providing sufﬁcient margin of time to guide and inﬂuence change at
the forefront of emerging technologies; 3) Interactivity broadens the agenda-
setting process by inviting various stakeholders and publics to the table and
encouraging them to take on a more active role in shaping both policy and
research through early identiﬁcation of relevant ethical, legal, and social
issues; and 4) Interdisciplinarity allows for synergistic and complementary
perspectives to ensure that both the scientiﬁc and normative dimensions of
knowledge creation evolve in step with one another. All four of these features
help contextualize science in society and achieve that higher level of “social
robustness” which Nowotny, Gibbons, and others referred to.
Acknowledging some of the arguments against integration, and in particu-
lar, the charge that the virtues of integration come at the cost of independence,
Zwart and Nelis contend that these are not either–or propositions. Integrated
ELSA researchers can and should exercise their intellectual autonomy in shap-
ing the research questions, and retain a critical and reﬂexive perspective in
answering them. They suggest “something similar to participatory criticism is
a viable option” (Zwart and Nelis, 2009). Along the same lines, other authors
suggest that “[a]lthough crossing the ocean of cultural divide between the sci-
ences remains their overall goal, ELSA researchers still have to take care of
their own research,” keeping up with developments and advancing knowledge
as independent and productive scholars in their own ﬁelds (Penders et al.,
2008).
GENOME CANADA’S GE3LS PROGRAM: A CASE STUDY
Genome Canada is the Canadian Government’s main strategic investor
in genomics research. Created as an independent, not-for-proﬁt corpora-
tion in 2000, Genome Canada funds large-scale, genomics and proteomics
projects across various sectors critical to Canada’s economy: human health,
forestry, ﬁsheries, agriculture, and the environment. Genome Canada also pro-
vides access to leading-edge technology through its Science and Technology
Innovation Centres. At time of publication, Genome Canada, the six regional
Genome Centres across the country3 and the research community had raised
over $1.7 billion in funding for genomics research in Canada, of which $915
million represents the Federal Government’s investment alone.4
Federal funding is contingent upon the terms and conditions of a funding
agreement between Genome Canada and the Federal Government, through
Industry Canada. This funding agreement sets out ﬁve (5) corporate objec-
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of ethical, environmental, economic, legal, social and other issues related
to genomics research (GE3LS) and the communication of the relative risks,
rewards, and successes of genomics to the Canadian public.”
In fulﬁlling this objective, Genome Canada innovated in several respects
from other ELSA, ELSI, or equivalent such programs that existed elsewhere
in the world. First, in creating its GE3LS program, Genome Canada added
two more “E’s” in its acronym, namely, economic and environmental implica-
tions of genomics. In so doing, it urged the research community to explicitly
consider not only the ethical, legal, and social aspects of genomics science, but
also potential trade-offs and longer-term impacts on the economy and the envi-
ronment, thereby expanding the “contextualization” process and the “social
robustness” of the research that it funds.
Second, Genome Canada, from its inception, made GE3LS-related projects
eligible for receiving large-scale grants. As a result, ten large-scale GE3LS
projects have been funded since 2000 providing close to $40 million in Genome
Canada funding and co-funding to support some of the largest projects Canada
had ever seen in these related disciplines.5 By sheer virtue of their scale, these
stand-alone GE3LS projects created the much-needed impetus to consolidate
GE3LS capacity at a critical juncture in the history of genomics funding in
Canada, and helped advance knowledge and leadership both nationally and
internationally.
Third, Genome Canada also funds smaller GE3LS projects that are inte-
grated as part of other large-scale genomics science projects.6 While applicants
from the natural sciences have always been expected to consider the ethical,
economic, environmental, legal, and social aspects of their proposed research,
the level of expectation has become more deﬁnitive from competition to compe-
tition. Likewise, the clarity of the expectation has been reﬁned over the course
of time.7
A 2006 study conducted by the European Research Area on Societal
Aspects of Genomics (ERASAGE) found Canada to be a “benchmark coun-
try” with its GE3LS research programs among the most “strongly developed”
(Nelis et al., 2006). A commissioned bibliometric analysis concluded that
Canada ranks 4th overall in GE3LS research using multicriteria rating from
1996–2007, on par with Australia, and behind the U.S., U.K., and Denmark
(Campbell et al., 2008). More recently, an external evaluation of Genome
Canada in May of 2009, which included a survey of a subsample of Genome
Canada-funded genomics scientists, GE3LS leaders of stand-alone projects,
technology platform leaders, peer reviewers, and other genomics research fun-
ders, measured Genome Canada’s performance against all ﬁve of its corporate
objectives, including leadership in GE3LS (KPMG, 2009). This KPMG report
found that Canada’s leadership in GE3LS research had improved substan-
tially since Genome Canada was created, from an average rating of “fair to
good” prior to Genome Canada, to an average rating of “excellent” now (KPMG,200 P . Kosseim and S. Chapman
2009). While several federal and provincial initiatives have contributed to
enhancing Canada’s leadership position in the area of GE3LS, a majority of
respondents believed that this change was either completely (8%), mainly
(38%), or partially (23%) due to Genome Canada and the regional Genome
Centres (KPMG, 2009).
In respect of the integration of GE3LS into large-scale genomics research
projects, 47% of respondents believed that Canada has done this well or
very well (KPMG, 2009). Much of this enthusiasm can be attributed partic-
ularly to the international respondents who regarded Canada’s experience
with GE3LS integration as faring better than that of their own countries.
International reviewers saw GE3LS integration “as a key deﬁning character-
istic of Genome Canada and very valuable” (KPMG, 2009). The results among
Canadian respondents, however, were more mixed:
... G E 3LS leaders commented that they are often not as integrated into
genomics science projects as they could be. They observed that they were some-
times “thrown together” with genomics scientists, with insufﬁcient time for real
teams to form, or to develop research themes in an ‘organic’ way. They further
commented that collaborations among the GE3LS scientists themselves were
often accidental and usually regional, not national. Several GE3LS leaders felt
isolated from each other, or noted the need for more internal capacity in their
ﬁeld. . .
On the genomics scientists’ part, a signiﬁcant number were not very con-
vinced of the usefulness of GE3LS. These topics were often considered a “tax” on
the science, and suffering from the GE3LS leaders not understanding genomics
sufﬁciently well, a possible over-emphasis on ethical aspects (with not enough
on socio-economic and environmental factors), and overall not being seen to have
much impact on Canadian genomics credibility (though, as noted earlier, many
of the internationals would not agree). It was noted, however, that GE3LS top-
ics that were well integrated with the science did, in fact, work well and were
u s e f u l ....( K P M G ,2009)
The tensions articulated above are also reﬂected in feedback received by
Genome Canada during various workshop consultations with the Canadian
research community and other stakeholders over the years (Green and
Hartley, 2007; Genome Canada, 2007; Williams, 2006; Hartley and Williams-
Jones, 2006; Sheremeta and Williams-Jones, 2002). Consultations revealed
that GE3LS integration has not always proceeded so smoothly or uniformly,
resulting in varying levels of collaboration between GE3LS and genomics
researchers. In practice, the integrated GE3LS components were regarded
by some as being “tacked on” to a genomics project in a last-minute rush
to meet application deadlines or as involving “forced marriages” between
genomics and GE3LS researchers in order to fulﬁl funding conditions. A
limited pool of GE3LS capacity in Canada, aggravated by institutional bar-
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difﬁcult to identify—let alone integrate—GE3LS researchers as project co-
investigators. Communication difﬁculties, cultural gaps, geographic distances,
diverse methodological approaches, and general mistrust of the unknown
all further added to the challenges of interdisciplinary team-building—
particularly in the early days.
Based on experience to date, those involved—either from the “science” or
“society” side—have had competing, sometimes colliding, expectations of what
should be the role of integrated GE3LS researchers in the context of large-scale
genomics research projects. These diverse expectations appear to be rooted in
different underlying assumptions of what GE3LS is intended to accomplish.
Some projects include GE3LS expertise on their Scientiﬁc Advisory Boards
to provide an external, independent, and critical perspective on the genomics
project during its design and implementation thereby creating the checks
and balances necessary to enhance the social legitimacy of the research
(oversight). Others view the role of GE3LS researchers as providing inter-
nal advisory services to the project scientists on what have primarily been
legal, ethical, and sociocultural issues requiring resolution in order to move
the project forward (advice). There are those who see integrated GE3LS as
a way of facilitating the interface between science and various end-users by,
for example, encouraging uptake of technology by practitioners, informing
evidence-based policies, regulations, and governance frameworks, enhancing
science literacy of the media, gauging public opinion, educating and engaging
communities to participate in relevant public debates (knowledge translation).
Some regard GE3LS integration as an opportunity for academics working
in GE3LS-related ﬁelds to conduct embedded research of their own, using
large-scale genomics projects as practical case studies and contributing to the
advancement of knowledge in their respective disciplines (embedded research).
Still others see it as an opportunity for both natural scientists and social
scientists/humanists to work together iteratively as part of an integrated,
interdisciplinary research team from the very outset, conceiving the research
proposal, shaping research questions, inﬂuencing research directions, carrying
out complementary research methods, and working in step to reach com-
mon milestones (integrated research). More often than not, integrated GE3LS
research is seen as some combination of these various purposes.
MOVING FORWARD
Despite the challenges and differences of opinion, what is more commonly
recognized is that successful integration of GE3LS research takes time.Truly
collaborative, trusting, and productive relationships need to be nurtured well
in advance of funding competitions to enable communication across differ-
ent disciplines, help bridge the cultural gaps between them, and match up202 P . Kosseim and S. Chapman
expectations. Time was a key theme emerging from the Genome Canada’s
informal workshop consultations (Green and Hartley, 2007) as well as KPMG’s
formal evaluation of Genome Canada (KPMG, 2009).
Genome Canada and the regional Genome Centres are not alone in work-
ing through these challenges. Other funding programs in other countries are
also facing many of the same issues, recognizing that resolution will take
time. Although cultural, communication, and credibility issues continue to per-
sist in the sometimes “prickly” relationship between natural scientists and
social scientists/humanists, some have observed “chinks” slowly beginning to
appear in the ﬁgurative wall which has traditionally divided these disciplines
(Macilwain, 2009).
Indeed, there are signs that science-society integration efforts can get
better over time. A valuable example of how integration models improve
iteratively through experience is illustrated by the improvements that were
made to the “Science and Society” component of European Commission’s Sixth
Framework Programme of 2002–2006.
The Sixth Framework Programme dedicated C88 million to “Science and
Society” research and activities aimed at developing more constructive and
effective communication and dialogue between the scientiﬁc community and
society at large (European Commission, 2002). An evaluation of the “Science
and Society” component of the Programme conducted in 2007 found, among
other things, that:
1. Only a minority of projects had addressed science and society issues, and
of those that did, signiﬁcant variations existed in terms of how much
attention was dedicated for that purpose;
2. Science and society issues were only vaguely addressed in formal program
documents (program descriptions, guidance for applicants, evaluation cri-
teria, reporting requirements, etc.) and informal guidance offered by
program staff, while clearly signiﬁcant, varied in terms of quality and
inﬂuence;
3. The relevance of science and society issues varied across different themes
and instruments; and
4. The general framing of the research agenda was an important factor in the
successful integration of science and society issues (European Commission,
2007).
The Evaluation Report recommended that: 1) deﬁnitions of science and soci-
ety issues should be made clearer and more precise; 2) convincing arguments
should be brought forward to demonstrate the relevance of science and soci-
ety issues in strengthening research capacity, achieving scientiﬁc excellence,
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to illustrate concretely how science and society issues can be addressed with
useful links to further information and tools.The Report also recommended
improving program descriptions, guidance documents, evaluation criteria
and procedures, monitoring systems, project proposal requirements, project
ofﬁcer training and capacity, and project reporting mechanisms (European
Commission, 2007).
At its conception, the Sixth Framework Programme set forth to bridge
the gap between science and society, implying a vision of science and soci-
ety as two distinct and separate entities which needed to be brought closer
together. Over time, however, it became evident that such a vision could not
be achieved by having scientists unilaterally disseminate information about
their scientiﬁc advances through broad public media. More needed to be done
to break down the barriers between scientists and citizens. Conceptually, the
vision evolved into one which regards scientists as forming an integral part
of society and having equally as much to learn about the world outside their
laboratory. Hence, the Seventh Framework Programme of 2007–2013 took a
more inclusive perspective of research within a wider societal and policy con-
text by adopting a “Science in Society” Work Programme. More than C330
million have been dedicated towards relevant activities aimed at more mean-
ingfully involving citizens and civil society in research and research-based
policies, and promoting more effective two-way dialogue that enables the public
to engage with science and vice versa (European Commission, 2007; European
Commission, 2007–2013; Gannon, 2006). Even with these improvements to the
7th Framework Programme, the European Commission recognizes that the
science-society debate is an ongoing one which continues to evolve and cannot
be conclusively closed one way or another (European Communities, 2009).
POSSIBLE MODELS FOR IMPROVING GENOME CANADA’S
INTEGRATED GE3LS RESEARCH PROGRAM
In light of all of the above, there are several options for improving GE3LS
integration going forward, recognizing that it will take time to get it right,
that the debate about how best to do it continues and that we should strive
to ﬁnd practical solutions, while remaining open to alternatives.8 Below are
simpliﬁed models of integration, illustrated by existing programs in Canada
which highlight basic differences in orientation. These models are summarized
in Table 1.
The Distributed Model: Doing it More and Doing it Better
One feasible option going forward is to continue to improve Genome
Canada’s current GE3LS integration model by remaining open and responsive
to possible improvement. We refer to this current model as the “distributed204 P . Kosseim and S. Chapman
Table 1: Summary Table of Some Made-in-Canada Integration Models
Model Type Example Advantages Challenges
Distributed
Model
Genome Canada’s
existing GE3LS
program consisting
of both large-scale
GE3LS projects and
integrated GE3LS
projects
Close proximity
between GE3LS
researchers and
scientists
Enhanced
relevance and
speciﬁcity of
GE3LS research
Applied,
case-study
approach to
studying
emerging
genomics
technologies
Isolated capacity
in individual
research projects
Potential
duplication and
redundancies
Interdisciplinary
teaming efforts
tend to be
limited by
regional
boundaries
Interactive
Model
VALGEN large-scale
GE3LS project
funded in 2009 by
Genome Canada
as part of its ABC
Competition
Same advantages
above, with
added value of
horizontal
integration and
synergy
Reduced potential
for duplication
Enhanced
potential for
national and
international
collaboration
Highly dependent
on collaboration
with those willing
to collaborate
Inherent
competition built
into the model
Complex
intellectual
property issues to
work through
Centralized
Model
McLaughlin-Rotman
Centre (MRC) ESC
Program funded in
2005 as part of the
Gates’ Foundation
Grand Challenges
in Global Health
Initiative
Relatively close
proximity
between ESC
capacity and
scientists
Potential for
coordination,
without
competition
Horizontal
overview and
understanding of
cross-cutting ESC
issues
Enabling of project
milestones
Flexibility of
involving
external experts
ESC issues
addressed
among only
those projects
requesting
assistance
Otherwise, no
other integrated
ESC capacity
within the
projects
ESC issues
identiﬁed only
after projects
have been
funded and
research
methods and
objectives have
been
establishedScience and Society 205
model” since each large-scale genomics project proposal is expected to have
its own integrated GE3LS component. Given its relatively recent conﬁrmation
as a mandatory funding criterion made explicit in 2005, there is still much
room for incremental enhancement. Similar to the European Framework expe-
rience, Canada too can learn from past experiences and improve upon them
both operationally and/or conceptually.
For instance, over the course of Genome Canada’s major competitions,
the percentage of funded large-scale science projects with integrated GE3LS
research plans has consistently increased over the years from 20% in
Competition I, 52% in Competition II, 57% in Applied Human Health, 87.5%
in Competition III, 100% in the Applied Genomics in Bioproducts or Crops
(ABC) Competition, and again 100% in the 2010 Large-Scale Applied Research
Competition.9
In Competition III, integrated GE3LS research received 1.6% of the total
funding support for all large-scale genomics science projects, and GE3LS
research accounted for 5.6% of overall funding if large-scale GE3LS projects
are also taken into account. In the ABC competition of 2009, those ﬁgures
increased to 4.8% and 9.3%, respectively. (At the time of publication, a total
of $60 million had been awarded to 16 successful genomics projects as part
of Genome Canada’s 2010 Large-Scale Applied Research Competition, but the
percentage breakdown representing integrated GE3LS components was not yet
known.)
While these ﬁgures are promising, they speak only to the quantitative
increases in the numbers of integrated GE3LS research projects and levels
of funding; they say little about the relative quality of the projects themselves
or how the “process” of integration was experienced over time. The challenges
of evaluating the quality of the integration experience are exacerbated in part
by the heterogeneity with which integration is perceived and operationalized
within individual projects.
Despite these evaluation challenges, some recent qualitative data are
beginning to demonstrate that the experience of GE3LS integration can get
better over time as a function of lessons learned. For instance, Genome B.C.
has recently carried out an evaluation comparing researchers’ experiences
with integrated GE3LS projects in Genome Canada’s Competition III program
(only those projects carried out in British Columbia) and researchers’ expe-
riences with integrated GE3LS projects in Genome B.C.’s Applied Genomics
Innovation Program (AGIP), a regional initiative launched three years later in
2007. Interviewees included researchers from the natural sciences and social
sciences and humanities, peer reviewers, and funders’ staff.
Preliminary data support the proposition that the integration experience
gets better as application guidelines and processes become clearer, review cri-
teria are reﬁned, funders’ staff provide active support for interdisciplinary206 P . Kosseim and S. Chapman
team-building, collaborative relationships among researchers strengthen over
time, and the research community eventually grows more accustomed to the
merits of the integration model. While the data are interim and limited to the
B.C. experience, they do sustain the more general hope that perseverance pays
off when appropriate incentives and support mechanisms are in place (Rodgers
et al., 2009).
Similarly, the most recent conditions and review criteria for GE3LS inte-
gration in Genome Canada’s 2010 Large-Scale Applied Research Competition
have been signiﬁcantly strengthened and clariﬁed from previous versions
which existed in former competition guidelines. These reﬁnements were a
deliberate response to past evaluation results and are the culmination of
lessons learned to date. Whether they are effective in better guiding research
applicants, strengthening integration efforts, and ultimately enhancing the
success of projects remains to be seen.
The principal advantage of this “distributed” model is that it ensures,
through built-in incentives and mandatory funding requirements, that every
large-scale project consider the societal aspects of the science it proposes,
that project leaders present a well-thought out research plan to address
these, subject to a rigorous peer review process, and that a speciﬁc por-
tion of the overall project budget be dedicated to support the GE3LS related
research and activities. GE3LS research, conducted in direct proximity to
the projects, is well-informed by the speciﬁcs of the science and vice-versa,
thereby enhancing the relevance, inﬂuence, and ultimate impact of the
research.
Even with the most reﬁned incentives and best support mechanisms in
place, however, the “distributed” model remains limited in some ways, by
virtue of its inherent features. For one, integrated GE3LS projects tend to
be isolated from one another, except for the occasional times when GE3LS
researchers will sporadically decide to collaborate together across projects.10
This does not tend to happen very often on its own given that most efforts
are already expended as it is on trying to integrate the GE3LS and scientiﬁc
aspects within the context of each individual large-scale project, leaving lit-
tle energy or resources available to work laterally across projects. Given the
lack of coordination across integrated projects, there is a risk of duplicating
efforts, particularly in the context of strategic competitions on targeted themes
where many of the societal aspects raised by the science are likely to be similar
across projects. And even with the best support mechanisms in place to pro-
mote networking and interdisciplinary team building by the regional Genome
Centres to increase GE3LS capacity and expand the breadth of GE3LS related
disciplines, these tend to be naturally limited by the geographic and jurisdic-
tional boundaries of each region, failing to capitalize on the full capacity and
expertise available on a wider, national basis.Science and Society 207
The Interactive Model: Integrating the Integrated
Options for enhancing the current Genome Canada GE3LS integration
model can be reﬁned not only at the operational level, through incremental
improvements over time, but conceptually as well, from fresh and creative
ideas brought forward by the research community itself. An example of this
is the “Value Addition through Genomics” (VALGEN) project—a large-scale,
stand-alone GE3LS project recently funded by Genome Canada as part of its
ABC competition. Through their innovative project, VALGEN researchers are
attempting to take the current model of GE3LS Integration to the “next level”
by horizontally integrating the integrated GE3LS components across the other
eleven large-scale genomics projects. With their $5.5M investment, VALGEN
researchers have as a primary objective to leverage the existing GE3LS capac-
ity in all projects and add value to the total ABC investment of almost $118M
in federal funding and co-funding combined (VALGEN).
VALGEN’s co-principal investigators11 have conceptualized their project
as a potential “dock” for the integrated GE3LS components of the other
projects—a national alliance of the willing, comprising a resource base and
“virtual common room” to promote networking, outreach, and partnership
opportunities. The VALGEN horizontal integration experiment involves a
formal network of interested GE3LS researchers across integrated projects,
that promotes collaboration on knowledge translation activities across insti-
tutions, across the country and supports capacity building through sabbatical
fellowships, new researcher training and researcher mobility programs.
In addition, the research component of VALGEN is using social sciences,
humanities, and legal scholarship to explore barriers to innovation in agri-
cultural biotechnology. In particular, the research team will focus on three
core substantive issues likely to be common across all ABC projects, namely,
intellectual property management and technology transfer; regulation and
governance; and democratic engagement. VALGEN research is not intended
to “supplant or replicate” existing research being conducted by the integrated
GE3LS projects funded under the ABC competition, but to synthesize research
outcomes speciﬁc to the technologies used in individual projects, at a more
general level of principle and abstraction, adding value across all projects.
This living laboratory of ‘integration’ will provide interesting outcomes
which, over time, may encourage the research community to come forward with
equivalent or further-improved proposals in future competitions. Targeted
competitions on strategic research themes would lend themselves particularly
well to this “next generation” model of integration.
Nevertheless, even this creative model of “interactive integration” has
some challenges to overcome. Chief among these is its critical dependence on
the willing collaboration of the integrated GE3LS leads in each project to inter-
act with other projects and to “dock” into the national coordinating project.
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naturally well. Otherwise, it may be challenging to garner the voluntary par-
ticipation of GE3LS leads horizontally across integrated projects, particularly
when these can only be identiﬁed after the fact, that is, after funding has been
awarded and the successful large-scale projects become known. Moreover, by
virtue of its inherent features, this model has built in a certain degree of com-
petition between the research conducted at the individual project level, and
the research conducted as part of the larger, stand-alone VALGEN project.
This may raise complex intellectual property issues which must be worked out
collaboratively in advance in order to clarify and manage expectations among
the researchers involved.
The Centralized Model: Taking a Broader, Programmatic
Approach
Another innovative variant of the integration model is illustrated by
the overarching Ethical, Social, and Cultural (ESC) Program of the Grand
Challenges for Global Health (GCGH), initiated by a Canadian team (Singer
and Lavery, 2003–2008) and sponsored by the Bill and Melinda Gates
Foundation. The GCGH initiative was launched in 2003 to identify and address
science and technology obstacles to resolving the fourteen most critical global
health challenges in the developing world. In 2005, 44 projects involving sci-
entists from 33 countries around the world received over $436 million in
funding to create “deliverable technologies,” deﬁned as “health tools that are
not only effective, but also inexpensive to produce, easy to distribute, and
simple to use in developing countries” (Grand Challenges in Global Health,
2005). Recognizing that successful completion of the projects depends not only
on doing good science, but also on addressing salient ethical, social, and cul-
tural issues, an ESC program was proposed and successfully funded in 2005
to: 1) advise GCGH projects on the ethical, social, and cultural issues that need
to be addressed in order to successfully achieve their project milestones; and
2) create a research program that can facilitate appropriate adoption of tech-
nologies that may arise from the funded GCGH projects over the long term
(Singer et al., 2007). The ESC program is based in Toronto, Canada, at the
McLaughlin-Rotman Centre for Global Health, and includes team members in
the developing world (McLaughlin-Rotman Centre for Global Health).12
In the ﬁrst year of operation, the ESC team provided advisory services to
24 of the 44 GCGH projects, and maintained ongoing engagement with the
remaining projects. In the second year of operation, the level of integration
was enhanced, and the ESC program’s capacity to anticipate and respond to
project-speciﬁc issues was increased, by assigning an ESC advisory service
leader and a lead bioethicist to each project, and instituting regular meet-
ings between ESC program staff and GCGH project ofﬁcers. The ESC advisory
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consultation with the GCGH project teams; identifying resources or materials
needed, including the assistance of outside expertise; researching the problem
through a review of the literature and other sources; and proposing draft solu-
tions to the GCGH investigators and staff. The ESC program staff then revises
the proposed solutions as needed and works with GCGH research teams to
implement the recommended actions.
The research activities of the ESC program have resulted in, as
examples:
1. A series of working papers, conceptual papers, and documentation of ESC
program activities to address speciﬁc issues that have not been adequately
covered in existing literature;
2. Commissioned research on priority issues for successful adoption of tech-
nologies coming out of GCGH projects;
3. Global case studies to identify good practices in community engagement
and commercialization of health technologies in low-resource settings; and
4. A demonstration project on Web-based public engagement revolving
around broad topics that are relevant to the GCGH initiative.
The ESC program aims to integrate its activities with that of the GCGH
projects by working closely with investigators to address ESC issues as they
arise. In contrast with Genome Canada’s distributed model by which each indi-
vidual funded genomics project must have an integrated GE3LS research plan
with the requisite GE3LS capacity to carry it out, the ESC program is an over-
arching, “centralized model” which provides advisory services (either directly
by the ESC team or through facilitated contact with other appropriate experts)
and facilitates necessary research to assist potentially all project investiga-
tors in addressing ESC issues within the funded GCGH projects. Whereas
the distributed integration model does not actively promote coordination of
GE3LS research plans between individual projects, the ESC program coor-
dinates input across GCGH teams and key informants to explore questions
around the adoption of new technologies with broad relevance to all GCGH
projects.
The centralized ESC program is similar to the interactive VALGEN model
in that both have as a key objective to coordinate research on the core ESC
or GE3LS-related aspects common to all funded projects. The main differences
between the centralized ESC model and the interactive VALGEN model, how-
ever, are twofold. First, the ESC model has as one of its primary functions to
provide advice to individual projects, which is not one of the stated objectives
of VALGEN. Second, the ESC model centralizes all of the ESC research capac-
ity in the overarching ESC Program, whereas the VALGEN model seeks to210 P . Kosseim and S. Chapman
“add value” to the already-existing GE3LS capacity which remains integrated
within each individual project.
One obvious advantage of the ESC “centralized model” (similar to the
VALGEN interactive model) is the coordination it allows across funded
projects, identifying common ethical, social, and cultural issues which exist
horizontally across projects, thereby reducing the potential for redundancies.
Another advantage of the ESC “centralized model” (similar to the “dis-
tributed model”) is the degree of proximity which exists between ESC
researchers and interested GCGH project leaders who request ESC assis-
tance in achieving project milestones. While the degree of proximity in the
centralized model is not always necessarily as close as that which ideally
exists between integrated GE3LS researchers and scientists in the distributed
model, it will vary depending on the issues/challenges at stake. For some
projects, there may be very deep integration of ESC components, whereas in
others where the ESC issues are less intense or complex, the level of ESC
involvement, if any, may be more modest. In other words, in the centralized
model, the degree of proximity between the ESC team and the project sci-
entists is not dictated by the design of the model itself, but rather, arises
organically by virtue of the complexity of the underlying issues or challenges at
stake.
Among potential challenges associated with the centralized model is the
fact that projects are not required to request assistance in addressing ESC
issues. Some may see the absence of such a mandatory funding requirement as
a disadvantage resulting in less comprehensive coverage than if projects were
in fact required to address ESC issues. Others, however, would contend that
this is in fact a beneﬁt since not all projects necessarily raise ESC issues, and
should therefore not be artiﬁcially forced to construct some. Moreover, those
who do come forward voluntarily to request assistance do so more willingly
and in a spirit open to collaboration once they themselves come to recognize
the critical need for ESC advice and research to assist them in achieving their
project objectives.
Another potential challenge associated with the centralized model has
to do with the timing with which the funding decisions are made. If a cen-
tralized ESC-like program is funded only after or at the same time as the
science projects are funded, then any assistance the ESC team may provide
the projects in identifying and addressing ESC issues will come necessarily
after-the-fact, that is, well after the scientiﬁc project methods and objectives
have already been established, thereby reducing their anticipatory potential
and their ability to shape the science. However, this challenge may be mit-
igated if the ESC program were funded in advance of making ﬁnal funding
decisions on the science projects. This would allow the centralized ESC team to
analyze ESC issues likely to arise, and have impact on how individual project
milestones are constructed.Science and Society 211
CONCLUSIONS
Whether one is contemplating the distributed model, the interactive model, or
the centralized model of GE3LS integration, there is always room for improve-
ment from a funder’s perspective. Strategic measures for improvement could
range from incremental reﬁnements on current approaches based on lessons
learned and shared among funders (such as Genome B.C.’s AGIP Program),
to incentivizing the research community itself to come forward with creative,
alternative models (such as the VALGEN project), to developing an innovative,
centralized platform for conducting GE3LS research, and providing GE3LS
related advice (such as the ESC Program of the Grand Challenges in Global
Health).
At the operational level, much can still be done to clarify the purpose
of integrated GE3LS and provide more helpful guidance through application
guidelines; improve the quality of GE3LS integration through more effective
incentives built into evaluation criteria and peer review processes; and provide
more staff support to promote interdisciplinary team-building both regionally,
and nationally. At the project level, strategic requests for proposals could help
encourage other VALGEN-like stand-alone projects to come forward with new
and creative ideas for integrating integrated projects in future thematic com-
petitions; integrated GE3LS researchers in individual projects could likewise
be incentivized to collaborate with others horizontally across projects as well.
At the program level, centralization of GE3LS capacity, similar to the MRC
ESC Program, if considered a potential future model, could be well estab-
lished prior to the call for scientiﬁc proposals, encouraging GE3LS consultation
further upstream in the project development process and helping guide the
determination of research questions, objectives, and methods from the very
outset.
Whatever may be the best model for GE3LS integration, it is important
not to lose sight of the substance for the form. In characterizing how the rela-
tionship between science and society evolved conceptually over time, Frank
Gannon reminds us of the conceptual shift that occurred between the “Science
and Society” of the Sixth Framework Programme, and the “Science in Society”
Work Programme of the Seventh Framework (Gannon, 2006). He goes on to
explain, however, that as society becomes more demanding, better at com-
municating its needs, and stronger in its resolve to hold institutions publicly
accountable, science must ﬁnd a humbler place in this new democratic space; it
must open up a new dialogue of trust and understanding, adapt to the choices
and priorities of society, and account for whether and how it will meet them.
“Science for Society” is how Gannon describes this next generation of dialogue
(Gannon, 2006).
Further to Gannon’s “and-in-for” trilogy of conjunctions and prepositions,
we wonder if it is not time to usher in a new era of “Science as Society.” Science212 P . Kosseim and S. Chapman
and technology have profound and permanent inﬂuence in shaping our lives,
our very identities, the world around us, and the future of our children. More
fundamentally, the ubiquitous nature of science and technology can change the
very way we see these things, the expectations we come to have of them, and
even our ability to be critical of them. To truly understand these inﬂuences,
we must reﬂect on more than what we want and need, and what can be done
and how. The dialogue must transcend the here and now, and go beyond the
immediate applications of science, to consider its larger implications, not only
for our society, but for other societies and future societies. This requires open,
inclusive, and participatory debate, further upstream in the development pro-
cess, to consider the kind of global society we want to live in and leave behind
for future generations. This, we believe, is the “function” ﬁrst and foremost,
which discussions about “form” must be made to follow.
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NOTES
1. Though we are not suggesting that the emergence of integration programs is the
inevitable outcome of the broader discussion about science and society, we do believe
it is informed—if not inﬂuenced—by it.
2. The recent Monitoring Activities of Science in Society in Europe (MASIS) Report
of the European Research Area provides an extensive discussion of several of these
trends (European Communities, 2009).
3. Genome B.C., Genome Alberta, Genome Prairies, Ontario Genome Institute,
Genome Québec, Genome Atlantic.
4. The balance of the $1.7 billion is co-funding by provincial governments, charitable
organizations, and private sector.
5. http://www.genomecanada.ca/en/ge3ls/research/.
6. Lay summaries of integrated GE3LS projects funded by Genome Canada
can be accessed online at http://www.genomecanada.ca/en/portfolio/research/
competition3.aspx for Competition III 2005–06 and at http://www. genome-
canada.ca/en/portfolio/research/applied.aspx for the Competition in Applied Genomics
Research in Bioproducts or Crops (ABC). At the time of publication, lay summaries
of the integrated GE3LS components of genomics projects funded as part of the 2010
Large-Scale Applied Research Competition were not yet available.
7. For example, in Competition I (April 2001) and Competition II (July 2001), each
regional Centre was responsible for establishing a research program in GE3LS. In
the Applied Human Health Competition (May 2003), applicants were asked to take
into account any relevant GE3LS issues or considerations. In Competition III (July
2004), applicants had to consider the GE3LS aspects of their proposed research and,
where appropriate, seek advice from one or more GE3LS experts to develop a plan toScience and Society 213
address those GE3LS issues directly raised by the proposed research. In the Applied
Genomics Research in Bioproducts or Crops (ABC) (April 2008), all applicants had
to consider the GE3LS issues arising from their proposed research and develop a
plan to address them. In the 2010 Large-Scale Applied Research Competition (May
2010), application guidelines were further reﬁned to clarify the role of the GE3LS
co-applicant(s), their active engagement throughout the research planning and imple-
mentation phases, and their contribution to the overall genomics project as active
member(s) of the research team. More speciﬁcally, “GE3LS co-applicants are expected
to develop a scholarly research plan that is aligned with, and complementary to,
the proposed milestones of the overall genomics project. The GE3LS research plan
should involve a systematic investigation designed to advance generalizable knowl-
edge in relevant academic ﬁelds that can be applied to the proposed genomics
project, as well as other similar projects or applications.” And, “GE3LS co-applicants
are encouraged to coordinate, wherever possible, with other GE3LS researchers
working on similar questions in other Genome Canada-funded projects to maxi-
mize opportunities for synergies and minimize potential duplication” (see Genome
Canada’s Guidelines for Funding Large-scale Research, May 2010, pp. 5–6: Available
at http://www.genomecanada.ca/medias/pdf/en/guidelines-competition-2010.pdf).
8. It is important to recognize that much valuable social sciences and humanities
(SSH) research gets done outside integration models. However, for the purposes of this
article, we have chosen to focus on integration models as means of conceptualizing,
organizing, and funding SSH research in relation to science.
9. Although GE3LS integration has always been encouraged of Genome Canada
applicants, the “mandatory” wording of the requirement became clearer in
Competition III and clearer still in the ABC Competition, see descriptions above.
10. See as an example, Feature article “To Share or not to share—
Should genetic test results be reported back to participants?” in Genome
Canada’s electronic GE3LS newsletter, Impact: Genomics and Society.
Available at http://www.genomecanada.ca/en/ge3ls/newsletters/fall-2009/feature-
stories.aspx#story-3.
11. Peter W. B. Phillips, Professor, Department of Political Studies, University of
Saskatchewan, and David Castle, Professor, Department of Philosophy, University of
Ottawa.
12. Principal investigators are Dr. Peter Singer and Dr. Abdallah Daar of the
University of Toronto and Dr. James Lavery of St. Michael’s Hospital, Toronto.
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